Analyst Price Target is $82.20
▲ +30.21% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for STAAR Surgical in the last 3 months. The average price target is $82.20, with a high forecast of $125.00 and a low forecast of $60.00. The average price target represents a 30.21% upside from the last price of $63.13.
Current Consensus is
The current consensus among 10 investment analysts is to buy stock in STAAR Surgical. This rating has held steady since January 2022, when it changed from a Hold consensus rating.
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.